| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0163-7258(93)90047-H |
| P8608 | Fatcat ID | release_oldebegxafbsljhiu5ky6mdzhi |
| P698 | PubMed publication ID | 8415876 |
| P50 | author | Jörg Huwyler | Q39717429 |
| P2093 | author name string | J Gut | |
| U Christen | |||
| P433 | issue | 2 | |
| P921 | main subject | halothane | Q32921 |
| P304 | page(s) | 133-155 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Mechanisms of halothane toxicity: novel insights | |
| P478 | volume | 58 |
| Q57302808 | 3 The pharmacology of the cytochrome P450 enzyme system |
| Q92006002 | Acute liver failure caused by occupational exposure to HCFC-123: Two case reports |
| Q54939025 | Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? |
| Q42588200 | Biochemical mechanisms in drug-induced liver injury: certainties and doubts. |
| Q36699786 | Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection |
| Q73943098 | Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies |
| Q57302817 | Chapter 37 Idiosyncratic drug reactions |
| Q51548369 | Characterization of the humoral immune response and hepatotoxicity after multiple halothane exposures in guinea pigs. |
| Q36662875 | Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology |
| Q41199724 | Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens |
| Q33638112 | Drug interactions during anesthesia. General principles |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q36238425 | General anesthesia in cardiac surgery: a review of drugs and practices. |
| Q46862508 | Halothane hepatotoxicity and hepatic free radical metabolism in guinea pigs; the effects of vitamin E. |
| Q37771144 | Hepatic drug-metabolizing enzyme induction and implications for preclinical and clinical risk assessment |
| Q30468681 | Hepatitis, rash and eosinophilia following trichloroethylene exposure: a case report and speculation on mechanistic similarity to halothane induced hepatitis |
| Q28080572 | Hepatotoxicity of halogenated inhalational anesthetics |
| Q42275274 | Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid |
| Q41172369 | Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism |
| Q35051172 | Immunopharmacology of hypersensitivity reactions to drugs |
| Q40564205 | In vitro analysis of metabolic predisposition to drug hypersensitivity reactions |
| Q47737546 | Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development |
| Q71571831 | Metabolism of phenytoin by the gingiva of normal humans: the possible role of reactive metabolites of phenytoin in the initiation of gingival hyperplasia |
| Q38218770 | Pathogen infection as a possible cause for autoimmune hepatitis. |
| Q46596868 | Peptide immunization restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes in cynomolgus monkeys |
| Q33781271 | Pharmacogenetics of cytochromes P450. |
| Q41460561 | Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis |
| Q51595612 | Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes |
| Q36439187 | Role of bioactivation in drug-induced hypersensitivity reactions |
| Q38687132 | Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity |
| Q43783069 | Selective inactivation of rat and bovine olfactory cytochrome P450 by three haloethanes. |
| Q51616395 | Stereoselective Metabolism of Halothane Enantiomers to Trifluoroacetylated Liver Proteins |
| Q56474940 | The Role of Active Metabolites in Drug Toxicity |
| Q35035447 | The danger hypothesis--potential role in idiosyncratic drug reactions |
| Q41656963 | The role of reactive drug metabolites in immune-mediated adverse drug reactions |
| Q40126705 | Trichloroethylene hypersensitivity syndrome: a disease of fatal outcome |
| Q35129123 | What is toxicology and how does toxicity occur? |
Search more.